UBS Lifts Price Target on Oruka Therapeutics to $100 From $75, Maintains Buy Rating
Idag, 15:21
Idag, 15:21
09:21 AM EDT, 04/28/2026 (MT Newswires) -- Oruka Therapeutics (ORKA) has an average rating of buy and mean price target of $136.62, according to analysts polled by FactSet.
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)
Idag, 15:21
09:21 AM EDT, 04/28/2026 (MT Newswires) -- Oruka Therapeutics (ORKA) has an average rating of buy and mean price target of $136.62, according to analysts polled by FactSet.
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)
Rapporter
Analys
Rapporter
Analys
1 DAG %
Senast
OMX Stockholm 30
−1,08%
(16:58)
Carasent
Idag, 16:30
Carasent: Köpvärd efter förvärvet?
oljepriset
Idag, 14:42
Förenade Arabemiraten lämnar Opec
OMX Stockholm 30
1 DAG %
Senast
3 047,07